Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for AI-induced Musculoskeletal Symptoms in Breast Cancer
NCT01809171Phase 3Terminated
- Sponsor
- UZ Leuven
- Start
- Oct 2013
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in aromatase inhibitor-associated musculoskeletal syndrome (AIMSS), sponsored by UZ Leuven. Started Oct 2013; status: terminated.
02
Drugs
vitamin d
03
Conditions
aromatase inhibitor-associated musculoskeletal syndrome (AIMSS)
Beyond the preview
Go deeper on NCT01809171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809171.